nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—CYP3A5—Disulfiram—alcohol dependence	0.131	0.306	CbGbCtD
Ponatinib—ABCB1—Naltrexone—alcohol dependence	0.0918	0.214	CbGbCtD
Ponatinib—ABCB1—Citalopram—alcohol dependence	0.0608	0.142	CbGbCtD
Ponatinib—CYP2D6—Citalopram—alcohol dependence	0.0573	0.134	CbGbCtD
Ponatinib—CYP3A4—Disulfiram—alcohol dependence	0.0511	0.119	CbGbCtD
Ponatinib—CYP3A4—Citalopram—alcohol dependence	0.0364	0.085	CbGbCtD
Ponatinib—ABCB11—bile—alcohol dependence	0.00952	0.0506	CbGeAlD
Ponatinib—KIT—seminiferous tubule of testis—alcohol dependence	0.00907	0.0482	CbGeAlD
Ponatinib—RET—autonomic nervous system—alcohol dependence	0.00651	0.0346	CbGeAlD
Ponatinib—FGFR4—brainstem—alcohol dependence	0.00334	0.0178	CbGeAlD
Ponatinib—FGFR4—digestive system—alcohol dependence	0.00227	0.012	CbGeAlD
Ponatinib—FGFR3—forebrain—alcohol dependence	0.0022	0.0117	CbGeAlD
Ponatinib—FGFR4—blood—alcohol dependence	0.00216	0.0115	CbGeAlD
Ponatinib—BCR—forebrain—alcohol dependence	0.00191	0.0101	CbGeAlD
Ponatinib—FGFR4—endocrine gland—alcohol dependence	0.00187	0.00994	CbGeAlD
Ponatinib—FGFR4—testis—alcohol dependence	0.00179	0.00948	CbGeAlD
Ponatinib—BCR—adrenal cortex—alcohol dependence	0.00177	0.00938	CbGeAlD
Ponatinib—FGFR4—nervous system—alcohol dependence	0.00175	0.0093	CbGeAlD
Ponatinib—FGFR3—gonad—alcohol dependence	0.00169	0.00897	CbGeAlD
Ponatinib—FGFR4—liver—alcohol dependence	0.00169	0.00896	CbGeAlD
Ponatinib—FGFR4—central nervous system—alcohol dependence	0.00169	0.00896	CbGeAlD
Ponatinib—FGFR4—cerebellum—alcohol dependence	0.00165	0.00876	CbGeAlD
Ponatinib—FLT3—cardiovascular system—alcohol dependence	0.0016	0.0085	CbGeAlD
Ponatinib—FGFR2—brainstem—alcohol dependence	0.00149	0.00793	CbGeAlD
Ponatinib—LYN—blood—alcohol dependence	0.00148	0.00786	CbGeAlD
Ponatinib—BCR—gonad—alcohol dependence	0.00146	0.00777	CbGeAlD
Ponatinib—FGFR3—midbrain—alcohol dependence	0.00145	0.00772	CbGeAlD
Ponatinib—FLT3—gonad—alcohol dependence	0.00145	0.00771	CbGeAlD
Ponatinib—FGFR2—forebrain—alcohol dependence	0.00144	0.00765	CbGeAlD
Ponatinib—FGFR4—brain—alcohol dependence	0.00134	0.00711	CbGeAlD
Ponatinib—Menopausal symptoms—Naltrexone—alcohol dependence	0.00129	0.0051	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00129	0.00508	CcSEcCtD
Ponatinib—Atrial fibrillation—Naltrexone—alcohol dependence	0.00128	0.00508	CcSEcCtD
Ponatinib—LYN—endocrine gland—alcohol dependence	0.00128	0.00682	CbGeAlD
Ponatinib—TEK—adrenal cortex—alcohol dependence	0.00128	0.0068	CbGeAlD
Ponatinib—FGFR3—endocrine gland—alcohol dependence	0.00128	0.00678	CbGeAlD
Ponatinib—BCR—blood—alcohol dependence	0.00127	0.00677	CbGeAlD
Ponatinib—Migraine—Acamprosate—alcohol dependence	0.00127	0.005	CcSEcCtD
Ponatinib—FLT3—blood—alcohol dependence	0.00127	0.00672	CbGeAlD
Ponatinib—BCR—midbrain—alcohol dependence	0.00126	0.00668	CbGeAlD
Ponatinib—PDGFRA—forebrain—alcohol dependence	0.00125	0.00665	CbGeAlD
Ponatinib—Lethargy—Naltrexone—alcohol dependence	0.00124	0.00491	CcSEcCtD
Ponatinib—Face oedema—Acamprosate—alcohol dependence	0.00124	0.00491	CcSEcCtD
Ponatinib—SRC—forebrain—alcohol dependence	0.00123	0.00652	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—alcohol dependence	0.00122	0.00647	CbGeAlD
Ponatinib—FGFR3—testis—alcohol dependence	0.00122	0.00647	CbGeAlD
Ponatinib—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00122	0.00481	CcSEcCtD
Ponatinib—Pain in extremity—Naltrexone—alcohol dependence	0.00122	0.00481	CcSEcCtD
Ponatinib—Cardiovascular disorder—Citalopram—alcohol dependence	0.00121	0.00478	CcSEcCtD
Ponatinib—Blood creatinine increased—Acamprosate—alcohol dependence	0.00121	0.00476	CcSEcCtD
Ponatinib—LYN—nervous system—alcohol dependence	0.0012	0.00638	CbGeAlD
Ponatinib—Migraine—Naltrexone—alcohol dependence	0.0012	0.00473	CcSEcCtD
Ponatinib—FGFR3—nervous system—alcohol dependence	0.0012	0.00635	CbGeAlD
Ponatinib—Dry skin—Acamprosate—alcohol dependence	0.00118	0.00466	CcSEcCtD
Ponatinib—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00118	0.00465	CcSEcCtD
Ponatinib—Face oedema—Naltrexone—alcohol dependence	0.00118	0.00464	CcSEcCtD
Ponatinib—TEK—cardiovascular system—alcohol dependence	0.00117	0.00621	CbGeAlD
Ponatinib—Cellulitis—Citalopram—alcohol dependence	0.00117	0.00462	CcSEcCtD
Ponatinib—Breast disorder—Acamprosate—alcohol dependence	0.00116	0.00459	CcSEcCtD
Ponatinib—Hypocalcaemia—Citalopram—alcohol dependence	0.00116	0.00459	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00116	0.00458	CcSEcCtD
Ponatinib—LYN—liver—alcohol dependence	0.00116	0.00615	CbGeAlD
Ponatinib—LYN—central nervous system—alcohol dependence	0.00116	0.00614	CbGeAlD
Ponatinib—Paraesthesia—Disulfiram—alcohol dependence	0.00115	0.00455	CcSEcCtD
Ponatinib—FGFR3—liver—alcohol dependence	0.00115	0.00612	CbGeAlD
Ponatinib—FGFR3—central nervous system—alcohol dependence	0.00115	0.00611	CbGeAlD
Ponatinib—TEK—pancreas—alcohol dependence	0.00114	0.00603	CbGeAlD
Ponatinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00113	0.00448	CcSEcCtD
Ponatinib—Dehydration—Naltrexone—alcohol dependence	0.00113	0.00447	CcSEcCtD
Ponatinib—KDR—forebrain—alcohol dependence	0.00113	0.006	CbGeAlD
Ponatinib—FGFR3—cerebellum—alcohol dependence	0.00113	0.00597	CbGeAlD
Ponatinib—Blood bilirubin increased—Citalopram—alcohol dependence	0.00112	0.00444	CcSEcCtD
Ponatinib—FGFR1—midbrain—alcohol dependence	0.00112	0.00595	CbGeAlD
Ponatinib—Abdominal distension—Acamprosate—alcohol dependence	0.00112	0.00442	CcSEcCtD
Ponatinib—Bone pain—Citalopram—alcohol dependence	0.00111	0.00438	CcSEcCtD
Ponatinib—Fatigue—Disulfiram—alcohol dependence	0.00111	0.00437	CcSEcCtD
Ponatinib—BCR—endocrine gland—alcohol dependence	0.00111	0.00587	CbGeAlD
Ponatinib—Pain—Disulfiram—alcohol dependence	0.0011	0.00434	CcSEcCtD
Ponatinib—FLT3—endocrine gland—alcohol dependence	0.0011	0.00583	CbGeAlD
Ponatinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.0011	0.00433	CcSEcCtD
Ponatinib—Pancreatitis—Acamprosate—alcohol dependence	0.00109	0.00431	CcSEcCtD
Ponatinib—Nasopharyngitis—Naltrexone—alcohol dependence	0.00109	0.0043	CcSEcCtD
Ponatinib—Angina pectoris—Acamprosate—alcohol dependence	0.00108	0.00428	CcSEcCtD
Ponatinib—Blood uric acid increased—Citalopram—alcohol dependence	0.00108	0.00428	CcSEcCtD
Ponatinib—Musculoskeletal pain—Citalopram—alcohol dependence	0.00108	0.00425	CcSEcCtD
Ponatinib—Neck pain—Citalopram—alcohol dependence	0.00108	0.00425	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00107	0.00424	CcSEcCtD
Ponatinib—RET—digestive system—alcohol dependence	0.00107	0.00566	CbGeAlD
Ponatinib—Pulmonary embolism—Citalopram—alcohol dependence	0.00106	0.0042	CcSEcCtD
Ponatinib—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00106	0.0042	CcSEcCtD
Ponatinib—PDGFRA—cardiovascular system—alcohol dependence	0.00106	0.00562	CbGeAlD
Ponatinib—BCR—testis—alcohol dependence	0.00105	0.0056	CbGeAlD
Ponatinib—KDR—adrenal cortex—alcohol dependence	0.00105	0.00556	CbGeAlD
Ponatinib—FLT3—testis—alcohol dependence	0.00105	0.00556	CbGeAlD
Ponatinib—ABCB11—digestive system—alcohol dependence	0.00104	0.00552	CbGeAlD
Ponatinib—SRC—cardiovascular system—alcohol dependence	0.00104	0.00551	CbGeAlD
Ponatinib—KIT—brainstem—alcohol dependence	0.00104	0.00551	CbGeAlD
Ponatinib—BCR—nervous system—alcohol dependence	0.00103	0.00549	CbGeAlD
Ponatinib—Influenza like illness—Citalopram—alcohol dependence	0.00103	0.00408	CcSEcCtD
Ponatinib—Angina pectoris—Naltrexone—alcohol dependence	0.00102	0.00405	CcSEcCtD
Ponatinib—Erectile dysfunction—Acamprosate—alcohol dependence	0.00102	0.00405	CcSEcCtD
Ponatinib—RET—blood—alcohol dependence	0.00101	0.00539	CbGeAlD
Ponatinib—LCK—blood—alcohol dependence	0.00101	0.00539	CbGeAlD
Ponatinib—FGFR2—digestive system—alcohol dependence	0.00101	0.00537	CbGeAlD
Ponatinib—SRC—pancreas—alcohol dependence	0.00101	0.00536	CbGeAlD
Ponatinib—Fluid retention—Citalopram—alcohol dependence	0.00101	0.00399	CcSEcCtD
Ponatinib—Abdominal discomfort—Naltrexone—alcohol dependence	0.00101	0.00399	CcSEcCtD
Ponatinib—Weight decreased—Acamprosate—alcohol dependence	0.00101	0.00398	CcSEcCtD
Ponatinib—Hyperglycaemia—Acamprosate—alcohol dependence	0.001	0.00396	CcSEcCtD
Ponatinib—RET—midbrain—alcohol dependence	0.001	0.00532	CbGeAlD
Ponatinib—Neuropathy—Citalopram—alcohol dependence	0.000998	0.00394	CcSEcCtD
Ponatinib—Pneumonia—Acamprosate—alcohol dependence	0.000997	0.00394	CcSEcCtD
Ponatinib—BCR—liver—alcohol dependence	0.000997	0.00529	CbGeAlD
Ponatinib—BCR—central nervous system—alcohol dependence	0.000996	0.00529	CbGeAlD
Ponatinib—FLT3—liver—alcohol dependence	0.00099	0.00525	CbGeAlD
Ponatinib—Dry eye—Citalopram—alcohol dependence	0.000981	0.00388	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000978	0.00386	CcSEcCtD
Ponatinib—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000977	0.00386	CcSEcCtD
Ponatinib—BCR—cerebellum—alcohol dependence	0.000974	0.00517	CbGeAlD
Ponatinib—Myocardial infarction—Acamprosate—alcohol dependence	0.000972	0.00384	CcSEcCtD
Ponatinib—FLT3—cerebellum—alcohol dependence	0.000967	0.00513	CbGeAlD
Ponatinib—Stomatitis—Acamprosate—alcohol dependence	0.000966	0.00382	CcSEcCtD
Ponatinib—FGFR2—blood—alcohol dependence	0.000964	0.00512	CbGeAlD
Ponatinib—Urinary tract infection—Acamprosate—alcohol dependence	0.000964	0.00381	CcSEcCtD
Ponatinib—PDGFRA—gonad—alcohol dependence	0.000961	0.0051	CbGeAlD
Ponatinib—Ecchymosis—Citalopram—alcohol dependence	0.000961	0.0038	CcSEcCtD
Ponatinib—KDR—cardiovascular system—alcohol dependence	0.000955	0.00507	CbGeAlD
Ponatinib—Weight decreased—Naltrexone—alcohol dependence	0.000952	0.00376	CcSEcCtD
Ponatinib—Pneumonia—Naltrexone—alcohol dependence	0.000944	0.00373	CcSEcCtD
Ponatinib—SRC—gonad—alcohol dependence	0.000943	0.005	CbGeAlD
Ponatinib—Infestation NOS—Naltrexone—alcohol dependence	0.000938	0.00371	CcSEcCtD
Ponatinib—Infestation—Naltrexone—alcohol dependence	0.000938	0.00371	CcSEcCtD
Ponatinib—FGFR1—testis—alcohol dependence	0.000938	0.00498	CbGeAlD
Ponatinib—Epistaxis—Acamprosate—alcohol dependence	0.000935	0.0037	CcSEcCtD
Ponatinib—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000925	0.00365	CcSEcCtD
Ponatinib—TEK—blood—alcohol dependence	0.000924	0.00491	CbGeAlD
Ponatinib—Sepsis—Citalopram—alcohol dependence	0.000922	0.00364	CcSEcCtD
Ponatinib—Asthenia—Disulfiram—alcohol dependence	0.000921	0.00364	CcSEcCtD
Ponatinib—Myocardial infarction—Naltrexone—alcohol dependence	0.00092	0.00363	CcSEcCtD
Ponatinib—LYN—brain—alcohol dependence	0.000919	0.00488	CbGeAlD
Ponatinib—FGFR3—brain—alcohol dependence	0.000914	0.00485	CbGeAlD
Ponatinib—TEK—midbrain—alcohol dependence	0.000913	0.00485	CbGeAlD
Ponatinib—Urinary tract infection—Naltrexone—alcohol dependence	0.000912	0.0036	CcSEcCtD
Ponatinib—ABL1—brainstem—alcohol dependence	0.000903	0.00479	CbGeAlD
Ponatinib—Haemoglobin—Acamprosate—alcohol dependence	0.000895	0.00353	CcSEcCtD
Ponatinib—Haemorrhage—Acamprosate—alcohol dependence	0.00089	0.00352	CcSEcCtD
Ponatinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000887	0.00351	CcSEcCtD
Ponatinib—FGFR1—liver—alcohol dependence	0.000887	0.00471	CbGeAlD
Ponatinib—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.000887	0.0035	CcSEcCtD
Ponatinib—Hypoaesthesia—Acamprosate—alcohol dependence	0.000886	0.0035	CcSEcCtD
Ponatinib—Epistaxis—Naltrexone—alcohol dependence	0.000885	0.0035	CcSEcCtD
Ponatinib—RET—endocrine gland—alcohol dependence	0.00088	0.00467	CbGeAlD
Ponatinib—PDGFRA—digestive system—alcohol dependence	0.000879	0.00467	CbGeAlD
Ponatinib—Oedema peripheral—Acamprosate—alcohol dependence	0.000877	0.00346	CcSEcCtD
Ponatinib—FGFR1—cerebellum—alcohol dependence	0.000866	0.0046	CbGeAlD
Ponatinib—SRC—digestive system—alcohol dependence	0.000862	0.00458	CbGeAlD
Ponatinib—ABCB11—endocrine gland—alcohol dependence	0.00086	0.00456	CbGeAlD
Ponatinib—Visual impairment—Acamprosate—alcohol dependence	0.000858	0.00339	CcSEcCtD
Ponatinib—Dizziness—Disulfiram—alcohol dependence	0.000849	0.00335	CcSEcCtD
Ponatinib—KIT—cardiovascular system—alcohol dependence	0.000847	0.00449	CbGeAlD
Ponatinib—LCK—testis—alcohol dependence	0.000839	0.00446	CbGeAlD
Ponatinib—RET—testis—alcohol dependence	0.000839	0.00446	CbGeAlD
Ponatinib—PDGFRA—blood—alcohol dependence	0.000838	0.00445	CbGeAlD
Ponatinib—FGFR2—endocrine gland—alcohol dependence	0.000836	0.00444	CbGeAlD
Ponatinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.000828	0.00327	CcSEcCtD
Ponatinib—Hot flush—Citalopram—alcohol dependence	0.000825	0.00326	CcSEcCtD
Ponatinib—RET—nervous system—alcohol dependence	0.000824	0.00437	CbGeAlD
Ponatinib—KIT—pancreas—alcohol dependence	0.000823	0.00437	CbGeAlD
Ponatinib—SRC—blood—alcohol dependence	0.000821	0.00436	CbGeAlD
Ponatinib—ABCB11—testis—alcohol dependence	0.00082	0.00435	CbGeAlD
Ponatinib—Menopausal symptoms—Citalopram—alcohol dependence	0.000817	0.00323	CcSEcCtD
Ponatinib—Atrial fibrillation—Citalopram—alcohol dependence	0.000814	0.00322	CcSEcCtD
Ponatinib—Rash—Disulfiram—alcohol dependence	0.000809	0.0032	CcSEcCtD
Ponatinib—ABL1—adrenal cortex—alcohol dependence	0.000808	0.00429	CbGeAlD
Ponatinib—Headache—Disulfiram—alcohol dependence	0.000804	0.00318	CcSEcCtD
Ponatinib—TEK—endocrine gland—alcohol dependence	0.000802	0.00426	CbGeAlD
Ponatinib—Chills—Acamprosate—alcohol dependence	0.000799	0.00316	CcSEcCtD
Ponatinib—FGFR2—testis—alcohol dependence	0.000798	0.00423	CbGeAlD
Ponatinib—LCK—liver—alcohol dependence	0.000794	0.00421	CbGeAlD
Ponatinib—RET—central nervous system—alcohol dependence	0.000793	0.00421	CbGeAlD
Ponatinib—KDR—digestive system—alcohol dependence	0.000793	0.00421	CbGeAlD
Ponatinib—BCR—brain—alcohol dependence	0.000791	0.0042	CbGeAlD
Ponatinib—Cardiac failure—Citalopram—alcohol dependence	0.00079	0.00312	CcSEcCtD
Ponatinib—Lethargy—Citalopram—alcohol dependence	0.000787	0.00311	CcSEcCtD
Ponatinib—Cerebrovascular accident—Citalopram—alcohol dependence	0.000787	0.00311	CcSEcCtD
Ponatinib—Eye disorder—Naltrexone—alcohol dependence	0.000787	0.00311	CcSEcCtD
Ponatinib—Alopecia—Acamprosate—alcohol dependence	0.000787	0.00311	CcSEcCtD
Ponatinib—FGFR2—nervous system—alcohol dependence	0.000783	0.00416	CbGeAlD
Ponatinib—Cardiac disorder—Naltrexone—alcohol dependence	0.000782	0.00309	CcSEcCtD
Ponatinib—Mental disorder—Acamprosate—alcohol dependence	0.00078	0.00308	CcSEcCtD
Ponatinib—RET—cerebellum—alcohol dependence	0.000775	0.00412	CbGeAlD
Ponatinib—ABCB11—liver—alcohol dependence	0.000775	0.00412	CbGeAlD
Ponatinib—Malnutrition—Acamprosate—alcohol dependence	0.000775	0.00306	CcSEcCtD
Ponatinib—Hyponatraemia—Citalopram—alcohol dependence	0.000774	0.00306	CcSEcCtD
Ponatinib—Pain in extremity—Citalopram—alcohol dependence	0.000771	0.00305	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000771	0.00305	CcSEcCtD
Ponatinib—KIT—gonad—alcohol dependence	0.000768	0.00408	CbGeAlD
Ponatinib—TEK—testis—alcohol dependence	0.000765	0.00406	CbGeAlD
Ponatinib—Angiopathy—Naltrexone—alcohol dependence	0.000764	0.00302	CcSEcCtD
Ponatinib—Migraine—Citalopram—alcohol dependence	0.000759	0.003	CcSEcCtD
Ponatinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000759	0.003	CcSEcCtD
Ponatinib—Chills—Naltrexone—alcohol dependence	0.000756	0.00299	CcSEcCtD
Ponatinib—KDR—blood—alcohol dependence	0.000756	0.00401	CbGeAlD
Ponatinib—FGFR2—liver—alcohol dependence	0.000754	0.004	CbGeAlD
Ponatinib—FGFR2—central nervous system—alcohol dependence	0.000754	0.004	CbGeAlD
Ponatinib—TEK—nervous system—alcohol dependence	0.00075	0.00398	CbGeAlD
Ponatinib—Back pain—Acamprosate—alcohol dependence	0.00075	0.00296	CcSEcCtD
Ponatinib—KDR—midbrain—alcohol dependence	0.000746	0.00396	CbGeAlD
Ponatinib—Muscle spasms—Acamprosate—alcohol dependence	0.000745	0.00294	CcSEcCtD
Ponatinib—Face oedema—Citalopram—alcohol dependence	0.000745	0.00294	CcSEcCtD
Ponatinib—Alopecia—Naltrexone—alcohol dependence	0.000744	0.00294	CcSEcCtD
Ponatinib—Mental disorder—Naltrexone—alcohol dependence	0.000738	0.00292	CcSEcCtD
Ponatinib—ABL1—cardiovascular system—alcohol dependence	0.000737	0.00391	CbGeAlD
Ponatinib—FGFR2—cerebellum—alcohol dependence	0.000737	0.00391	CbGeAlD
Ponatinib—Malnutrition—Naltrexone—alcohol dependence	0.000733	0.0029	CcSEcCtD
Ponatinib—PDGFRA—endocrine gland—alcohol dependence	0.000726	0.00386	CbGeAlD
Ponatinib—TEK—liver—alcohol dependence	0.000723	0.00384	CbGeAlD
Ponatinib—TEK—central nervous system—alcohol dependence	0.000723	0.00384	CbGeAlD
Ponatinib—Dehydration—Citalopram—alcohol dependence	0.000717	0.00283	CcSEcCtD
Ponatinib—ABL1—pancreas—alcohol dependence	0.000716	0.0038	CbGeAlD
Ponatinib—Anaemia—Acamprosate—alcohol dependence	0.000716	0.00283	CcSEcCtD
Ponatinib—SRC—endocrine gland—alcohol dependence	0.000712	0.00378	CbGeAlD
Ponatinib—Back pain—Naltrexone—alcohol dependence	0.000709	0.0028	CcSEcCtD
Ponatinib—Dry skin—Citalopram—alcohol dependence	0.000707	0.00279	CcSEcCtD
Ponatinib—TEK—cerebellum—alcohol dependence	0.000706	0.00375	CbGeAlD
Ponatinib—Muscle spasms—Naltrexone—alcohol dependence	0.000705	0.00278	CcSEcCtD
Ponatinib—FGFR1—brain—alcohol dependence	0.000704	0.00374	CbGeAlD
Ponatinib—KIT—digestive system—alcohol dependence	0.000703	0.00373	CbGeAlD
Ponatinib—Hypokalaemia—Citalopram—alcohol dependence	0.000702	0.00277	CcSEcCtD
Ponatinib—Breast disorder—Citalopram—alcohol dependence	0.000697	0.00275	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000695	0.00274	CcSEcCtD
Ponatinib—Leukopenia—Acamprosate—alcohol dependence	0.000694	0.00274	CcSEcCtD
Ponatinib—PDGFRA—testis—alcohol dependence	0.000693	0.00368	CbGeAlD
Ponatinib—Vision blurred—Naltrexone—alcohol dependence	0.000691	0.00273	CcSEcCtD
Ponatinib—Nasopharyngitis—Citalopram—alcohol dependence	0.00069	0.00273	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00068	0.00269	CcSEcCtD
Ponatinib—PDGFRA—nervous system—alcohol dependence	0.00068	0.00361	CbGeAlD
Ponatinib—SRC—testis—alcohol dependence	0.000679	0.00361	CbGeAlD
Ponatinib—Cough—Acamprosate—alcohol dependence	0.000676	0.00267	CcSEcCtD
Ponatinib—Abdominal distension—Citalopram—alcohol dependence	0.000671	0.00265	CcSEcCtD
Ponatinib—KIT—blood—alcohol dependence	0.00067	0.00355	CbGeAlD
Ponatinib—Hypertension—Acamprosate—alcohol dependence	0.000669	0.00264	CcSEcCtD
Ponatinib—ABL1—gonad—alcohol dependence	0.000669	0.00355	CbGeAlD
Ponatinib—SRC—nervous system—alcohol dependence	0.000667	0.00354	CbGeAlD
Ponatinib—KIT—midbrain—alcohol dependence	0.000661	0.00351	CbGeAlD
Ponatinib—Arthralgia—Acamprosate—alcohol dependence	0.00066	0.00261	CcSEcCtD
Ponatinib—Myalgia—Acamprosate—alcohol dependence	0.00066	0.00261	CcSEcCtD
Ponatinib—KDR—endocrine gland—alcohol dependence	0.000655	0.00348	CbGeAlD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000655	0.00259	CcSEcCtD
Ponatinib—PDGFRA—liver—alcohol dependence	0.000655	0.00348	CbGeAlD
Ponatinib—PDGFRA—central nervous system—alcohol dependence	0.000655	0.00348	CbGeAlD
Ponatinib—Pancreatitis—Citalopram—alcohol dependence	0.000654	0.00258	CcSEcCtD
Ponatinib—Angina pectoris—Citalopram—alcohol dependence	0.000649	0.00257	CcSEcCtD
Ponatinib—Dry mouth—Acamprosate—alcohol dependence	0.000645	0.00255	CcSEcCtD
Ponatinib—SRC—liver—alcohol dependence	0.000642	0.00341	CbGeAlD
Ponatinib—SRC—central nervous system—alcohol dependence	0.000642	0.00341	CbGeAlD
Ponatinib—PDGFRA—cerebellum—alcohol dependence	0.00064	0.0034	CbGeAlD
Ponatinib—Cough—Naltrexone—alcohol dependence	0.00064	0.00253	CcSEcCtD
Ponatinib—Abdominal discomfort—Citalopram—alcohol dependence	0.000639	0.00253	CcSEcCtD
Ponatinib—Pancytopenia—Citalopram—alcohol dependence	0.000633	0.0025	CcSEcCtD
Ponatinib—Hypertension—Naltrexone—alcohol dependence	0.000633	0.0025	CcSEcCtD
Ponatinib—RET—brain—alcohol dependence	0.00063	0.00334	CbGeAlD
Ponatinib—Infection—Acamprosate—alcohol dependence	0.000628	0.00248	CcSEcCtD
Ponatinib—SRC—cerebellum—alcohol dependence	0.000627	0.00333	CbGeAlD
Ponatinib—KDR—testis—alcohol dependence	0.000625	0.00332	CbGeAlD
Ponatinib—Myalgia—Naltrexone—alcohol dependence	0.000624	0.00247	CcSEcCtD
Ponatinib—Arthralgia—Naltrexone—alcohol dependence	0.000624	0.00247	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00062	0.00245	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00062	0.00245	CcSEcCtD
Ponatinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000619	0.00245	CcSEcCtD
Ponatinib—Skin disorder—Acamprosate—alcohol dependence	0.000614	0.00243	CcSEcCtD
Ponatinib—Erectile dysfunction—Citalopram—alcohol dependence	0.000614	0.00243	CcSEcCtD
Ponatinib—KDR—nervous system—alcohol dependence	0.000613	0.00326	CbGeAlD
Ponatinib—ABL1—digestive system—alcohol dependence	0.000612	0.00325	CbGeAlD
Ponatinib—Hyperhidrosis—Acamprosate—alcohol dependence	0.000611	0.00242	CcSEcCtD
Ponatinib—Dry mouth—Naltrexone—alcohol dependence	0.00061	0.00241	CcSEcCtD
Ponatinib—Weight decreased—Citalopram—alcohol dependence	0.000603	0.00238	CcSEcCtD
Ponatinib—Hyperglycaemia—Citalopram—alcohol dependence	0.000601	0.00238	CcSEcCtD
Ponatinib—Oedema—Naltrexone—alcohol dependence	0.000598	0.00236	CcSEcCtD
Ponatinib—FGFR2—brain—alcohol dependence	0.000598	0.00318	CbGeAlD
Ponatinib—Pneumonia—Citalopram—alcohol dependence	0.000598	0.00236	CcSEcCtD
Ponatinib—Infection—Naltrexone—alcohol dependence	0.000594	0.00235	CcSEcCtD
Ponatinib—Infestation NOS—Citalopram—alcohol dependence	0.000594	0.00235	CcSEcCtD
Ponatinib—Infestation—Citalopram—alcohol dependence	0.000594	0.00235	CcSEcCtD
Ponatinib—KDR—liver—alcohol dependence	0.000591	0.00314	CbGeAlD
Ponatinib—KDR—central nervous system—alcohol dependence	0.000591	0.00313	CbGeAlD
Ponatinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000587	0.00232	CcSEcCtD
Ponatinib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000586	0.00232	CcSEcCtD
Ponatinib—ABL1—blood—alcohol dependence	0.000583	0.00309	CbGeAlD
Ponatinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.000583	0.0023	CcSEcCtD
Ponatinib—Myocardial infarction—Citalopram—alcohol dependence	0.000583	0.0023	CcSEcCtD
Ponatinib—Skin disorder—Naltrexone—alcohol dependence	0.000581	0.0023	CcSEcCtD
Ponatinib—KIT—endocrine gland—alcohol dependence	0.000581	0.00308	CbGeAlD
Ponatinib—Stomatitis—Citalopram—alcohol dependence	0.000579	0.00229	CcSEcCtD
Ponatinib—Jaundice—Citalopram—alcohol dependence	0.000579	0.00229	CcSEcCtD
Ponatinib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000578	0.00229	CcSEcCtD
Ponatinib—Urinary tract infection—Citalopram—alcohol dependence	0.000578	0.00228	CcSEcCtD
Ponatinib—KDR—cerebellum—alcohol dependence	0.000577	0.00306	CbGeAlD
Ponatinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000576	0.00228	CcSEcCtD
Ponatinib—ABL1—midbrain—alcohol dependence	0.000576	0.00306	CbGeAlD
Ponatinib—TEK—brain—alcohol dependence	0.000574	0.00305	CbGeAlD
Ponatinib—Insomnia—Acamprosate—alcohol dependence	0.000572	0.00226	CcSEcCtD
Ponatinib—Paraesthesia—Acamprosate—alcohol dependence	0.000568	0.00224	CcSEcCtD
Ponatinib—Dyspnoea—Acamprosate—alcohol dependence	0.000564	0.00223	CcSEcCtD
Ponatinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000562	0.00222	CcSEcCtD
Ponatinib—Epistaxis—Citalopram—alcohol dependence	0.000561	0.00222	CcSEcCtD
Ponatinib—Dyspepsia—Acamprosate—alcohol dependence	0.000557	0.0022	CcSEcCtD
Ponatinib—KIT—testis—alcohol dependence	0.000554	0.00294	CbGeAlD
Ponatinib—Decreased appetite—Acamprosate—alcohol dependence	0.00055	0.00217	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000546	0.00216	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000545	0.00215	CcSEcCtD
Ponatinib—KIT—nervous system—alcohol dependence	0.000544	0.00289	CbGeAlD
Ponatinib—Insomnia—Naltrexone—alcohol dependence	0.000541	0.00214	CcSEcCtD
Ponatinib—Constipation—Acamprosate—alcohol dependence	0.000541	0.00214	CcSEcCtD
Ponatinib—Pain—Acamprosate—alcohol dependence	0.000541	0.00214	CcSEcCtD
Ponatinib—Paraesthesia—Naltrexone—alcohol dependence	0.000537	0.00212	CcSEcCtD
Ponatinib—Haemoglobin—Citalopram—alcohol dependence	0.000536	0.00212	CcSEcCtD
Ponatinib—Haemorrhage—Citalopram—alcohol dependence	0.000534	0.00211	CcSEcCtD
Ponatinib—Dyspnoea—Naltrexone—alcohol dependence	0.000533	0.00211	CcSEcCtD
Ponatinib—Hypoaesthesia—Citalopram—alcohol dependence	0.000531	0.0021	CcSEcCtD
Ponatinib—Oedema peripheral—Citalopram—alcohol dependence	0.000526	0.00208	CcSEcCtD
Ponatinib—Connective tissue disorder—Citalopram—alcohol dependence	0.000524	0.00207	CcSEcCtD
Ponatinib—KIT—liver—alcohol dependence	0.000524	0.00278	CbGeAlD
Ponatinib—KIT—central nervous system—alcohol dependence	0.000523	0.00278	CbGeAlD
Ponatinib—Decreased appetite—Naltrexone—alcohol dependence	0.00052	0.00206	CcSEcCtD
Ponatinib—PDGFRA—brain—alcohol dependence	0.00052	0.00276	CbGeAlD
Ponatinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000517	0.00204	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000517	0.00204	CcSEcCtD
Ponatinib—Fatigue—Naltrexone—alcohol dependence	0.000516	0.00204	CcSEcCtD
Ponatinib—Visual impairment—Citalopram—alcohol dependence	0.000514	0.00203	CcSEcCtD
Ponatinib—Constipation—Naltrexone—alcohol dependence	0.000512	0.00202	CcSEcCtD
Ponatinib—Pain—Naltrexone—alcohol dependence	0.000512	0.00202	CcSEcCtD
Ponatinib—KIT—cerebellum—alcohol dependence	0.000511	0.00272	CbGeAlD
Ponatinib—SRC—brain—alcohol dependence	0.00051	0.00271	CbGeAlD
Ponatinib—ABCG2—adrenal cortex—alcohol dependence	0.000509	0.0027	CbGeAlD
Ponatinib—ABL1—endocrine gland—alcohol dependence	0.000506	0.00268	CbGeAlD
Ponatinib—Body temperature increased—Acamprosate—alcohol dependence	0.0005	0.00198	CcSEcCtD
Ponatinib—Abdominal pain—Acamprosate—alcohol dependence	0.0005	0.00198	CcSEcCtD
Ponatinib—Eye disorder—Citalopram—alcohol dependence	0.000499	0.00197	CcSEcCtD
Ponatinib—Cardiac disorder—Citalopram—alcohol dependence	0.000495	0.00196	CcSEcCtD
Ponatinib—Flushing—Citalopram—alcohol dependence	0.000495	0.00196	CcSEcCtD
Ponatinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000489	0.00193	CcSEcCtD
Ponatinib—Angiopathy—Citalopram—alcohol dependence	0.000484	0.00191	CcSEcCtD
Ponatinib—ABL1—testis—alcohol dependence	0.000482	0.00256	CbGeAlD
Ponatinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000481	0.0019	CcSEcCtD
Ponatinib—Chills—Citalopram—alcohol dependence	0.000479	0.00189	CcSEcCtD
Ponatinib—Arrhythmia—Citalopram—alcohol dependence	0.000477	0.00188	CcSEcCtD
Ponatinib—ABL1—nervous system—alcohol dependence	0.000473	0.00251	CbGeAlD
Ponatinib—Abdominal pain—Naltrexone—alcohol dependence	0.000473	0.00187	CcSEcCtD
Ponatinib—Body temperature increased—Naltrexone—alcohol dependence	0.000473	0.00187	CcSEcCtD
Ponatinib—Alopecia—Citalopram—alcohol dependence	0.000472	0.00186	CcSEcCtD
Ponatinib—KDR—brain—alcohol dependence	0.000469	0.00249	CbGeAlD
Ponatinib—Mental disorder—Citalopram—alcohol dependence	0.000467	0.00185	CcSEcCtD
Ponatinib—Erythema—Citalopram—alcohol dependence	0.000465	0.00184	CcSEcCtD
Ponatinib—Malnutrition—Citalopram—alcohol dependence	0.000465	0.00184	CcSEcCtD
Ponatinib—ABL1—liver—alcohol dependence	0.000456	0.00242	CbGeAlD
Ponatinib—ABL1—central nervous system—alcohol dependence	0.000456	0.00242	CbGeAlD
Ponatinib—Asthenia—Acamprosate—alcohol dependence	0.000454	0.00179	CcSEcCtD
Ponatinib—Back pain—Citalopram—alcohol dependence	0.000449	0.00178	CcSEcCtD
Ponatinib—Pruritus—Acamprosate—alcohol dependence	0.000447	0.00177	CcSEcCtD
Ponatinib—Muscle spasms—Citalopram—alcohol dependence	0.000447	0.00176	CcSEcCtD
Ponatinib—ABL1—cerebellum—alcohol dependence	0.000445	0.00236	CbGeAlD
Ponatinib—Vision blurred—Citalopram—alcohol dependence	0.000438	0.00173	CcSEcCtD
Ponatinib—Diarrhoea—Acamprosate—alcohol dependence	0.000433	0.00171	CcSEcCtD
Ponatinib—Anaemia—Citalopram—alcohol dependence	0.000429	0.0017	CcSEcCtD
Ponatinib—Asthenia—Naltrexone—alcohol dependence	0.000429	0.0017	CcSEcCtD
Ponatinib—Pruritus—Naltrexone—alcohol dependence	0.000423	0.00167	CcSEcCtD
Ponatinib—CYP3A5—pancreas—alcohol dependence	0.000419	0.00223	CbGeAlD
Ponatinib—Dizziness—Acamprosate—alcohol dependence	0.000418	0.00165	CcSEcCtD
Ponatinib—Leukopenia—Citalopram—alcohol dependence	0.000416	0.00164	CcSEcCtD
Ponatinib—KIT—brain—alcohol dependence	0.000415	0.00221	CbGeAlD
Ponatinib—Diarrhoea—Naltrexone—alcohol dependence	0.000409	0.00162	CcSEcCtD
Ponatinib—Cough—Citalopram—alcohol dependence	0.000405	0.0016	CcSEcCtD
Ponatinib—Vomiting—Acamprosate—alcohol dependence	0.000402	0.00159	CcSEcCtD
Ponatinib—Hypertension—Citalopram—alcohol dependence	0.000401	0.00158	CcSEcCtD
Ponatinib—Rash—Acamprosate—alcohol dependence	0.000399	0.00158	CcSEcCtD
Ponatinib—Dermatitis—Acamprosate—alcohol dependence	0.000398	0.00157	CcSEcCtD
Ponatinib—Headache—Acamprosate—alcohol dependence	0.000396	0.00157	CcSEcCtD
Ponatinib—Dizziness—Naltrexone—alcohol dependence	0.000396	0.00156	CcSEcCtD
Ponatinib—Myalgia—Citalopram—alcohol dependence	0.000395	0.00156	CcSEcCtD
Ponatinib—Arthralgia—Citalopram—alcohol dependence	0.000395	0.00156	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000393	0.00155	CcSEcCtD
Ponatinib—CYP2D6—brainstem—alcohol dependence	0.00039	0.00207	CbGeAlD
Ponatinib—Dry mouth—Citalopram—alcohol dependence	0.000387	0.00153	CcSEcCtD
Ponatinib—Vomiting—Naltrexone—alcohol dependence	0.00038	0.0015	CcSEcCtD
Ponatinib—Oedema—Citalopram—alcohol dependence	0.000379	0.0015	CcSEcCtD
Ponatinib—CYP2C8—blood—alcohol dependence	0.000378	0.00201	CbGeAlD
Ponatinib—Rash—Naltrexone—alcohol dependence	0.000377	0.00149	CcSEcCtD
Ponatinib—Dermatitis—Naltrexone—alcohol dependence	0.000377	0.00149	CcSEcCtD
Ponatinib—CYP2D6—forebrain—alcohol dependence	0.000377	0.002	CbGeAlD
Ponatinib—Infection—Citalopram—alcohol dependence	0.000377	0.00149	CcSEcCtD
Ponatinib—Nausea—Acamprosate—alcohol dependence	0.000376	0.00148	CcSEcCtD
Ponatinib—Headache—Naltrexone—alcohol dependence	0.000375	0.00148	CcSEcCtD
Ponatinib—Nervous system disorder—Citalopram—alcohol dependence	0.000372	0.00147	CcSEcCtD
Ponatinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000371	0.00147	CcSEcCtD
Ponatinib—Skin disorder—Citalopram—alcohol dependence	0.000368	0.00145	CcSEcCtD
Ponatinib—ABCG2—blood—alcohol dependence	0.000368	0.00195	CbGeAlD
Ponatinib—Hyperhidrosis—Citalopram—alcohol dependence	0.000366	0.00145	CcSEcCtD
Ponatinib—ABCG2—midbrain—alcohol dependence	0.000363	0.00193	CbGeAlD
Ponatinib—ABL1—brain—alcohol dependence	0.000362	0.00192	CbGeAlD
Ponatinib—CYP3A5—digestive system—alcohol dependence	0.000358	0.0019	CbGeAlD
Ponatinib—Nausea—Naltrexone—alcohol dependence	0.000355	0.0014	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000345	0.00136	CcSEcCtD
Ponatinib—Insomnia—Citalopram—alcohol dependence	0.000343	0.00135	CcSEcCtD
Ponatinib—CYP3A5—blood—alcohol dependence	0.000341	0.00181	CbGeAlD
Ponatinib—Paraesthesia—Citalopram—alcohol dependence	0.00034	0.00135	CcSEcCtD
Ponatinib—Dyspnoea—Citalopram—alcohol dependence	0.000338	0.00134	CcSEcCtD
Ponatinib—Dyspepsia—Citalopram—alcohol dependence	0.000334	0.00132	CcSEcCtD
Ponatinib—Decreased appetite—Citalopram—alcohol dependence	0.00033	0.0013	CcSEcCtD
Ponatinib—CYP2C8—endocrine gland—alcohol dependence	0.000328	0.00174	CbGeAlD
Ponatinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000327	0.00129	CcSEcCtD
Ponatinib—Fatigue—Citalopram—alcohol dependence	0.000327	0.00129	CcSEcCtD
Ponatinib—Pain—Citalopram—alcohol dependence	0.000324	0.00128	CcSEcCtD
Ponatinib—Constipation—Citalopram—alcohol dependence	0.000324	0.00128	CcSEcCtD
Ponatinib—CYP2C8—testis—alcohol dependence	0.000313	0.00166	CbGeAlD
Ponatinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.00031	0.00122	CcSEcCtD
Ponatinib—ABCG2—testis—alcohol dependence	0.000304	0.00161	CbGeAlD
Ponatinib—Body temperature increased—Citalopram—alcohol dependence	0.0003	0.00118	CcSEcCtD
Ponatinib—Abdominal pain—Citalopram—alcohol dependence	0.0003	0.00118	CcSEcCtD
Ponatinib—CYP3A5—endocrine gland—alcohol dependence	0.000296	0.00157	CbGeAlD
Ponatinib—CYP2C8—liver—alcohol dependence	0.000296	0.00157	CbGeAlD
Ponatinib—ABCG2—liver—alcohol dependence	0.000287	0.00153	CbGeAlD
Ponatinib—ABCG2—cerebellum—alcohol dependence	0.000281	0.00149	CbGeAlD
Ponatinib—Asthenia—Citalopram—alcohol dependence	0.000272	0.00107	CcSEcCtD
Ponatinib—ABCB1—forebrain—alcohol dependence	0.000271	0.00144	CbGeAlD
Ponatinib—CYP3A4—digestive system—alcohol dependence	0.000269	0.00143	CbGeAlD
Ponatinib—Pruritus—Citalopram—alcohol dependence	0.000268	0.00106	CcSEcCtD
Ponatinib—CYP3A5—liver—alcohol dependence	0.000267	0.00142	CbGeAlD
Ponatinib—CYP2D6—digestive system—alcohol dependence	0.000264	0.0014	CbGeAlD
Ponatinib—Diarrhoea—Citalopram—alcohol dependence	0.000259	0.00102	CcSEcCtD
Ponatinib—CYP3A4—blood—alcohol dependence	0.000256	0.00136	CbGeAlD
Ponatinib—CYP2D6—blood—alcohol dependence	0.000252	0.00134	CbGeAlD
Ponatinib—ABCB1—adrenal cortex—alcohol dependence	0.000251	0.00133	CbGeAlD
Ponatinib—Dizziness—Citalopram—alcohol dependence	0.000251	0.000991	CcSEcCtD
Ponatinib—Vomiting—Citalopram—alcohol dependence	0.000241	0.000952	CcSEcCtD
Ponatinib—Rash—Citalopram—alcohol dependence	0.000239	0.000944	CcSEcCtD
Ponatinib—Dermatitis—Citalopram—alcohol dependence	0.000239	0.000944	CcSEcCtD
Ponatinib—Headache—Citalopram—alcohol dependence	0.000237	0.000938	CcSEcCtD
Ponatinib—CYP2C8—brain—alcohol dependence	0.000235	0.00125	CbGeAlD
Ponatinib—ABCB1—cardiovascular system—alcohol dependence	0.000229	0.00122	CbGeAlD
Ponatinib—ABCG2—brain—alcohol dependence	0.000228	0.00121	CbGeAlD
Ponatinib—Nausea—Citalopram—alcohol dependence	0.000225	0.00089	CcSEcCtD
Ponatinib—ABCB1—pancreas—alcohol dependence	0.000223	0.00118	CbGeAlD
Ponatinib—CYP3A4—endocrine gland—alcohol dependence	0.000222	0.00118	CbGeAlD
Ponatinib—CYP2D6—endocrine gland—alcohol dependence	0.000219	0.00116	CbGeAlD
Ponatinib—CYP2D6—testis—alcohol dependence	0.000208	0.00111	CbGeAlD
Ponatinib—ABCB1—gonad—alcohol dependence	0.000208	0.0011	CbGeAlD
Ponatinib—CYP3A4—nervous system—alcohol dependence	0.000208	0.0011	CbGeAlD
Ponatinib—CYP2D6—nervous system—alcohol dependence	0.000205	0.00109	CbGeAlD
Ponatinib—CYP3A4—liver—alcohol dependence	0.0002	0.00106	CbGeAlD
Ponatinib—CYP3A4—central nervous system—alcohol dependence	0.0002	0.00106	CbGeAlD
Ponatinib—CYP2D6—liver—alcohol dependence	0.000197	0.00105	CbGeAlD
Ponatinib—CYP2D6—central nervous system—alcohol dependence	0.000197	0.00105	CbGeAlD
Ponatinib—CYP2D6—cerebellum—alcohol dependence	0.000192	0.00102	CbGeAlD
Ponatinib—ABCB1—digestive system—alcohol dependence	0.00019	0.00101	CbGeAlD
Ponatinib—ABCB1—blood—alcohol dependence	0.000181	0.000962	CbGeAlD
Ponatinib—ABCB1—midbrain—alcohol dependence	0.000179	0.00095	CbGeAlD
Ponatinib—ABCB1—endocrine gland—alcohol dependence	0.000157	0.000835	CbGeAlD
Ponatinib—CYP2D6—brain—alcohol dependence	0.000156	0.00083	CbGeAlD
Ponatinib—ABCB1—testis—alcohol dependence	0.00015	0.000796	CbGeAlD
Ponatinib—ABCB1—nervous system—alcohol dependence	0.000147	0.000781	CbGeAlD
Ponatinib—ABCB1—liver—alcohol dependence	0.000142	0.000752	CbGeAlD
Ponatinib—ABCB1—central nervous system—alcohol dependence	0.000142	0.000752	CbGeAlD
Ponatinib—ABCB1—cerebellum—alcohol dependence	0.000138	0.000735	CbGeAlD
Ponatinib—ABCB1—brain—alcohol dependence	0.000112	0.000597	CbGeAlD
Ponatinib—FGFR2—Disease—GOT1—alcohol dependence	4.95e-05	0.000381	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—DRD4—alcohol dependence	4.92e-05	0.000379	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—OPRM1—alcohol dependence	4.91e-05	0.000378	CbGpPWpGaD
Ponatinib—KIT—Disease—GOT1—alcohol dependence	4.86e-05	0.000374	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CRHR1—alcohol dependence	4.75e-05	0.000366	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—WASF2—alcohol dependence	4.75e-05	0.000366	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—GOT2—alcohol dependence	4.73e-05	0.000364	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.71e-05	0.000363	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CNR1—alcohol dependence	4.69e-05	0.000361	CbGpPWpGaD
Ponatinib—CYP2D6—Biological oxidations—POMC—alcohol dependence	4.69e-05	0.000361	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—OPRM1—alcohol dependence	4.66e-05	0.000359	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—OPRM1—alcohol dependence	4.65e-05	0.000358	CbGpPWpGaD
Ponatinib—FGFR1—Disease—GOT1—alcohol dependence	4.61e-05	0.000355	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NPY—alcohol dependence	4.6e-05	0.000354	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—GOT1—alcohol dependence	4.6e-05	0.000354	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—DRD2—alcohol dependence	4.58e-05	0.000353	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR7—alcohol dependence	4.58e-05	0.000353	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—WASF1—alcohol dependence	4.55e-05	0.000351	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NPY—alcohol dependence	4.52e-05	0.000348	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CHRM2—alcohol dependence	4.47e-05	0.000344	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH1A—alcohol dependence	4.45e-05	0.000343	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CYP2E1—alcohol dependence	4.45e-05	0.000343	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR1B—alcohol dependence	4.44e-05	0.000342	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CRH—alcohol dependence	4.44e-05	0.000342	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AVP—alcohol dependence	4.43e-05	0.000341	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—OPRD1—alcohol dependence	4.37e-05	0.000336	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR1B—alcohol dependence	4.36e-05	0.000336	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CRH—alcohol dependence	4.36e-05	0.000336	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADH4—alcohol dependence	4.34e-05	0.000335	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—MAOB—alcohol dependence	4.33e-05	0.000333	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NPY—alcohol dependence	4.29e-05	0.00033	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NPY—alcohol dependence	4.28e-05	0.000329	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ADH7—alcohol dependence	4.27e-05	0.000328	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH1A—alcohol dependence	4.2e-05	0.000323	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PDYN—alcohol dependence	4.19e-05	0.000323	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CRH—alcohol dependence	4.14e-05	0.000319	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR1B—alcohol dependence	4.14e-05	0.000319	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CRH—alcohol dependence	4.13e-05	0.000318	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR1B—alcohol dependence	4.13e-05	0.000318	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—OPRM1—alcohol dependence	4.1e-05	0.000316	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGT2—alcohol dependence	4.09e-05	0.000315	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—GGT1—alcohol dependence	4.08e-05	0.000314	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—GOT1—alcohol dependence	4.08e-05	0.000314	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—EP300—alcohol dependence	4.08e-05	0.000314	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—POMC—alcohol dependence	3.98e-05	0.000306	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—WASF2—alcohol dependence	3.89e-05	0.0003	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CRHR1—alcohol dependence	3.89e-05	0.0003	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—DRD4—alcohol dependence	3.88e-05	0.000299	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—OPRD1—alcohol dependence	3.87e-05	0.000298	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AVP—alcohol dependence	3.85e-05	0.000297	CbGpPWpGaD
Ponatinib—LCK—Disease—GOT2—alcohol dependence	3.85e-05	0.000297	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—DRD4—alcohol dependence	3.81e-05	0.000294	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH4—alcohol dependence	3.79e-05	0.000291	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NPY—alcohol dependence	3.77e-05	0.000291	CbGpPWpGaD
Ponatinib—FGFR4—Disease—EP300—alcohol dependence	3.77e-05	0.00029	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.76e-05	0.00029	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—EP300—alcohol dependence	3.76e-05	0.00029	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—EP300—alcohol dependence	3.74e-05	0.000288	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ADH1B—alcohol dependence	3.74e-05	0.000288	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—WASF1—alcohol dependence	3.73e-05	0.000287	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PDYN—alcohol dependence	3.71e-05	0.000286	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CNR1—alcohol dependence	3.71e-05	0.000285	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADH7—alcohol dependence	3.69e-05	0.000284	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HTR2A—alcohol dependence	3.68e-05	0.000284	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALDH2—alcohol dependence	3.68e-05	0.000283	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	3.66e-05	0.000282	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—MAOA—alcohol dependence	3.66e-05	0.000282	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CRH—alcohol dependence	3.64e-05	0.00028	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR1B—alcohol dependence	3.64e-05	0.00028	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CNR1—alcohol dependence	3.64e-05	0.00028	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—DRD4—alcohol dependence	3.62e-05	0.000279	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—DRD2—alcohol dependence	3.62e-05	0.000278	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR7—alcohol dependence	3.62e-05	0.000278	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	3.61e-05	0.000278	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH4—alcohol dependence	3.57e-05	0.000275	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—EP300—alcohol dependence	3.56e-05	0.000274	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR7—alcohol dependence	3.55e-05	0.000273	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—DRD2—alcohol dependence	3.55e-05	0.000273	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.55e-05	0.000273	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGT2—alcohol dependence	3.54e-05	0.000273	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—EP300—alcohol dependence	3.5e-05	0.000269	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CNR1—alcohol dependence	3.45e-05	0.000266	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CRHR1—alcohol dependence	3.45e-05	0.000265	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—WASF2—alcohol dependence	3.45e-05	0.000265	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	3.45e-05	0.000265	CbGpPWpGaD
Ponatinib—SRC—Disease—GOT2—alcohol dependence	3.41e-05	0.000263	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—DRD2—alcohol dependence	3.37e-05	0.00026	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR7—alcohol dependence	3.37e-05	0.00026	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	3.36e-05	0.000259	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	3.36e-05	0.000259	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	3.36e-05	0.000259	CbGpPWpGaD
Ponatinib—LCK—Disease—GOT1—alcohol dependence	3.33e-05	0.000256	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—EP300—alcohol dependence	3.32e-05	0.000256	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—EP300—alcohol dependence	3.31e-05	0.000255	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH6—alcohol dependence	3.31e-05	0.000255	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—EP300—alcohol dependence	3.31e-05	0.000255	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.31e-05	0.000255	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—WASF1—alcohol dependence	3.31e-05	0.000255	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—EP300—alcohol dependence	3.29e-05	0.000254	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—EP300—alcohol dependence	3.25e-05	0.00025	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CHRM2—alcohol dependence	3.24e-05	0.00025	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADH1B—alcohol dependence	3.24e-05	0.000249	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—EP300—alcohol dependence	3.23e-05	0.000249	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH7—alcohol dependence	3.22e-05	0.000248	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HTR2A—alcohol dependence	3.21e-05	0.000247	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—DRD4—alcohol dependence	3.18e-05	0.000245	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GOT2—alcohol dependence	3.13e-05	0.000241	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MAOB—alcohol dependence	3.1e-05	0.000239	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NPY—alcohol dependence	3.09e-05	0.000238	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGT2—alcohol dependence	3.09e-05	0.000238	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.07e-05	0.000236	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AVP—alcohol dependence	3.04e-05	0.000234	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CNR1—alcohol dependence	3.04e-05	0.000234	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	3.04e-05	0.000234	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH7—alcohol dependence	3.03e-05	0.000234	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—EP300—alcohol dependence	3.02e-05	0.000232	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AVP—alcohol dependence	2.99e-05	0.00023	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	2.98e-05	0.00023	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CRH—alcohol dependence	2.98e-05	0.00023	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—OPRM1—alcohol dependence	2.98e-05	0.000229	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—DRD2—alcohol dependence	2.97e-05	0.000228	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR7—alcohol dependence	2.97e-05	0.000228	CbGpPWpGaD
Ponatinib—SRC—Disease—GOT1—alcohol dependence	2.95e-05	0.000227	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—POMC—alcohol dependence	2.94e-05	0.000226	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	2.94e-05	0.000226	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—EP300—alcohol dependence	2.92e-05	0.000225	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—EP300—alcohol dependence	2.91e-05	0.000224	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGT2—alcohol dependence	2.91e-05	0.000224	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AVP—alcohol dependence	2.84e-05	0.000218	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	2.83e-05	0.000218	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH1B—alcohol dependence	2.82e-05	0.000217	CbGpPWpGaD
Ponatinib—FGFR3—Disease—EP300—alcohol dependence	2.79e-05	0.000215	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.74e-05	0.000211	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NPY—alcohol dependence	2.74e-05	0.000211	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	2.74e-05	0.000211	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GGT1—alcohol dependence	2.7e-05	0.000208	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GOT1—alcohol dependence	2.7e-05	0.000208	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MAOB—alcohol dependence	2.68e-05	0.000207	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—EP300—alcohol dependence	2.66e-05	0.000205	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH1B—alcohol dependence	2.66e-05	0.000205	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CRH—alcohol dependence	2.64e-05	0.000203	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR1B—alcohol dependence	2.64e-05	0.000203	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—EP300—alcohol dependence	2.64e-05	0.000203	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	2.64e-05	0.000203	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—DRD4—alcohol dependence	2.61e-05	0.000201	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—POMC—alcohol dependence	2.56e-05	0.000197	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HTR2A—alcohol dependence	2.53e-05	0.000195	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AVP—alcohol dependence	2.5e-05	0.000192	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CNR1—alcohol dependence	2.49e-05	0.000192	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HTR2A—alcohol dependence	2.49e-05	0.000192	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—DRD2—alcohol dependence	2.43e-05	0.000187	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR7—alcohol dependence	2.43e-05	0.000187	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—MAOA—alcohol dependence	2.42e-05	0.000186	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—EP300—alcohol dependence	2.4e-05	0.000185	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—EP300—alcohol dependence	2.39e-05	0.000184	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—POMC—alcohol dependence	2.38e-05	0.000183	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HTR2A—alcohol dependence	2.36e-05	0.000182	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—EP300—alcohol dependence	2.35e-05	0.000181	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	2.35e-05	0.000181	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MAOB—alcohol dependence	2.34e-05	0.00018	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH4—alcohol dependence	2.33e-05	0.00018	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—DRD4—alcohol dependence	2.31e-05	0.000178	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALDH2—alcohol dependence	2.28e-05	0.000176	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT2—alcohol dependence	2.24e-05	0.000173	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CNR1—alcohol dependence	2.21e-05	0.00017	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MAOB—alcohol dependence	2.2e-05	0.00017	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.19e-05	0.000169	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR7—alcohol dependence	2.15e-05	0.000166	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—DRD2—alcohol dependence	2.15e-05	0.000166	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—EP300—alcohol dependence	2.12e-05	0.000163	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	2.11e-05	0.000162	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HTR2A—alcohol dependence	2.08e-05	0.00016	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—EP300—alcohol dependence	2.08e-05	0.00016	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AVP—alcohol dependence	2.05e-05	0.000158	CbGpPWpGaD
Ponatinib—KIT—Immune System—EP300—alcohol dependence	2.04e-05	0.000157	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—POMC—alcohol dependence	2.02e-05	0.000156	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.99e-05	0.000153	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—POMC—alcohol dependence	1.99e-05	0.000153	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.98e-05	0.000153	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—EP300—alcohol dependence	1.95e-05	0.00015	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT2—alcohol dependence	1.94e-05	0.000149	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—EP300—alcohol dependence	1.93e-05	0.000149	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGT1—alcohol dependence	1.93e-05	0.000149	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT1—alcohol dependence	1.93e-05	0.000149	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—EP300—alcohol dependence	1.93e-05	0.000149	CbGpPWpGaD
Ponatinib—FGFR2—Disease—EP300—alcohol dependence	1.92e-05	0.000148	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.9e-05	0.000146	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—POMC—alcohol dependence	1.89e-05	0.000145	CbGpPWpGaD
Ponatinib—KIT—Disease—EP300—alcohol dependence	1.88e-05	0.000145	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	1.88e-05	0.000145	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.87e-05	0.000144	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.82e-05	0.000141	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AVP—alcohol dependence	1.81e-05	0.000139	CbGpPWpGaD
Ponatinib—FGFR1—Disease—EP300—alcohol dependence	1.79e-05	0.000138	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—EP300—alcohol dependence	1.78e-05	0.000137	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.74e-05	0.000134	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MAOA—alcohol dependence	1.73e-05	0.000133	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	1.7e-05	0.000131	CbGpPWpGaD
Ponatinib—LYN—Immune System—EP300—alcohol dependence	1.7e-05	0.000131	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—EP300—alcohol dependence	1.7e-05	0.000131	CbGpPWpGaD
Ponatinib—ABL1—Immune System—EP300—alcohol dependence	1.69e-05	0.00013	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT2—alcohol dependence	1.69e-05	0.00013	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT1—alcohol dependence	1.68e-05	0.000129	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGT1—alcohol dependence	1.68e-05	0.000129	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—POMC—alcohol dependence	1.66e-05	0.000128	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT2—alcohol dependence	1.59e-05	0.000123	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.59e-05	0.000122	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—EP300—alcohol dependence	1.58e-05	0.000122	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—POMC—alcohol dependence	1.57e-05	0.000121	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2A—alcohol dependence	1.51e-05	0.000116	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MAOA—alcohol dependence	1.5e-05	0.000116	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.5e-05	0.000115	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT1—alcohol dependence	1.46e-05	0.000112	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGT1—alcohol dependence	1.46e-05	0.000112	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.46e-05	0.000112	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MAOB—alcohol dependence	1.44e-05	0.000111	CbGpPWpGaD
Ponatinib—LCK—Immune System—EP300—alcohol dependence	1.39e-05	0.000107	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGT1—alcohol dependence	1.38e-05	0.000106	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT1—alcohol dependence	1.38e-05	0.000106	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—POMC—alcohol dependence	1.36e-05	0.000105	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EP300—alcohol dependence	1.34e-05	0.000103	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EP300—alcohol dependence	1.32e-05	0.000101	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MAOA—alcohol dependence	1.31e-05	0.000101	CbGpPWpGaD
Ponatinib—LCK—Disease—EP300—alcohol dependence	1.29e-05	9.92e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EP300—alcohol dependence	1.25e-05	9.63e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	1.25e-05	9.6e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—EP300—alcohol dependence	1.23e-05	9.51e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MAOA—alcohol dependence	1.23e-05	9.49e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.23e-05	9.43e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—alcohol dependence	1.2e-05	9.27e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—EP300—alcohol dependence	1.14e-05	8.78e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—alcohol dependence	1.13e-05	8.69e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EP300—alcohol dependence	1.1e-05	8.47e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—EP300—alcohol dependence	1.04e-05	8.05e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT2—alcohol dependence	1.04e-05	8.02e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	9.79e-06	7.54e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—alcohol dependence	9.77e-06	7.53e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EP300—alcohol dependence	9.02e-06	6.94e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT1—alcohol dependence	8.99e-06	6.92e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT1—alcohol dependence	8.99e-06	6.92e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—alcohol dependence	8.52e-06	6.56e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MAOA—alcohol dependence	8.06e-06	6.2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—alcohol dependence	8.02e-06	6.18e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EP300—alcohol dependence	7.98e-06	6.15e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—EP300—alcohol dependence	7.49e-06	5.76e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—EP300—alcohol dependence	6.48e-06	4.99e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—EP300—alcohol dependence	5.65e-06	4.35e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—EP300—alcohol dependence	5.32e-06	4.1e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—alcohol dependence	5.25e-06	4.04e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—EP300—alcohol dependence	3.48e-06	2.68e-05	CbGpPWpGaD
